FDA Advisers Vote To Recommend Authorization Of Pill To Treat COVID-19If authorization is granted, the drug would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form.
Merck Envisions Billions From COVID-19 Treatment SalesMerck fell out of the race to develop COVID-19 vaccines earlier this year but could vault to head of the pack for treatments in 2022.
Ann Arbor's Lycera In Collaboration With Pharma Giant MerckThe Ann Arbor pharma startup Lycera Corp. Tuesday announced a collaboration with pharma giant Merck to discover, developand commercialize small-molecule therapies directed at novel targets to treat a broad range of immune system disorders.
Lycera Achieves First Milestone in Merck Research CollaborationLycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.
NanoBio In RSV Vaccine Research Effort With MerckNanobio Corp. Thursday announced a preclinical collaboration with a subsidiary of Merck & Co. Inc. focused on the development of a vaccine for Respiratory Syncytial Virus (RSV).
'Build Smart, Breathe Easier' Dedicates House With Asthma-Healthy Features with Detroit FamilyThe first Habitat for Humanity house built as part of the 'Build Smart, Breathe Easier' national asthma education program will be dedicated in partnership with the Dunmore family in Detroit on Friday, July 29.
Lycera Announces Research Collaboration with MerckThe Plymouth-based biopharmaceutical developer Lycera Corp. Thursday announced an exclusive research collaboration with pharma giant Merck to develop drug candidates that have the potential to treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis
Perrigo Confirms Filing For New Generic